ZDA
ARRY

Zweig-DiMenna Associates’s Array Biopharma Inc ARRY Stock Holding History

Zweig-DiMenna Associates’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-590,640
Closed -$27.4M – 125
2019
Q2 		$27.4M Buy
+590,640
New +$16.6M 2.6% 6

Other funds holding ARRY

ASN
Advisory Services Network Atlanta, Georgia $8.83B AUM 38.5% 1-Year Est. Return

Zweig-DiMenna Associates's ARRY Position: Q3 2019 in Review

Zweig-DiMenna Associates sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 590,640 shares — an estimated $27.4M sold.

Zweig-DiMenna Associates first reported a position in ARRY in Q2 2019 and held it in 1 quarter. The position peaked at $27.4M in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

  • Zweig-DiMenna Associates reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
  • Zweig-DiMenna Associates sold 590,640 Array Biopharma Inc shares in Q3 2019, an estimated $27.4M.
  • Zweig-DiMenna Associates first reported a position in Array Biopharma Inc in Q2 2019 and held it in 1 quarter.
  • Zweig-DiMenna Associates's Array Biopharma Inc position peaked at $27.4M in Q2 2019.
  • 1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Zweig-DiMenna Associates's 13F filing for Q3 2019, filed 31 Oct 2019.